Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -2.66% | 567.04 | 2.7% | $651.45m | |
| GILD | Gilead Sciences, Inc. | -2.15% | 58.72 | 1.0% | $577.62m | |
| AMGN | Amgen, Inc. | -3.17% | 216.38 | 1.3% | $567.02m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.81% | 208.34 | 1.9% | $534.17m | |
| MRNA | Moderna, Inc. | -6.98% | 65.74 | 0.0% | $415.50m | |
| ILMN | Illumina, Inc. | -3.75% | 309.69 | 3.5% | $397.23m | |
| EXAS | EXACT Sciences Corp. | -2.75% | 127.52 | 20.7% | $297.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -4.29% | 114.85 | 2.0% | $259.81m | |
| BIIB | Biogen, Inc. | -4.32% | 244.26 | 1.7% | $251.09m | |
| NVAX | Novavax, Inc. | -9.22% | 81.33 | 96.5% | $238.36m | |
| BNTX | BioNTech SE | -7.64% | 77.54 | 0.0% | $198.15m | |
| SRRK | Scholar Rock Holding Corp. | 44.67% | 43.43 | 0.0% | $174.98m | |
| SGEN | Seagen Inc. | -1.05% | 194.85 | 6.0% | $144.96m | |
| SRNE | Sorrento Therapeutics, Inc. | -8.04% | 7.09 | 1.4% | $135.51m | |
| CRSP | CRISPR Therapeutics AG | -3.48% | 94.71 | 0.6% | $123.39m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.